| Primary |
| Product Used For Unknown Indication |
31.3% |
| Benign Prostatic Hyperplasia |
20.2% |
| Alopecia |
15.9% |
| Androgenetic Alopecia |
7.1% |
| Prostatomegaly |
6.9% |
| Prostatic Disorder |
3.5% |
| Drug Use For Unknown Indication |
2.0% |
| Hypertension |
2.0% |
| Bladder Disorder |
1.7% |
| Back Pain |
1.4% |
| Prostate Cancer |
1.3% |
| Benign Neoplasm Of Prostate |
1.2% |
| Nocturia |
1.0% |
| Oedema |
0.9% |
| Diabetes Mellitus |
0.7% |
| Blood Pressure Increased |
0.6% |
| Dressler's Syndrome |
0.6% |
| Hirsutism |
0.6% |
| Hyperthyroidism |
0.6% |
| Micturition Urgency |
0.6% |
|
| Loss Of Libido |
8.8% |
| Gynaecomastia |
7.8% |
| Depression |
5.9% |
| Testicular Pain |
5.9% |
| Cerebrovascular Accident |
5.4% |
| Dizziness |
5.4% |
| Erectile Dysfunction |
5.4% |
| Prostate Cancer |
5.4% |
| Drug Interaction |
4.9% |
| Product Substitution Issue |
4.9% |
| Suicidal Ideation |
4.9% |
| Drug Ineffective |
4.4% |
| Libido Decreased |
4.4% |
| Urinary Retention |
4.4% |
| Flatulence |
3.9% |
| Hallucination |
3.9% |
| Hyperthyroidism |
3.9% |
| Testicular Swelling |
3.9% |
| Urinary Tract Inflammation |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
63.8% |
| Alopecia |
7.6% |
| Benign Prostatic Hyperplasia |
5.7% |
| Androgenetic Alopecia |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Hypertension |
2.5% |
| Depression |
1.7% |
| Prostatic Disorder |
1.4% |
| Diabetes Mellitus |
1.2% |
| Prostate Cancer |
1.2% |
| Parkinson's Disease |
1.1% |
| Urinary Retention |
1.0% |
| Seborrhoeic Dermatitis |
0.9% |
| Alanine Aminotransferase Increased |
0.8% |
| Oedema |
0.8% |
| Oedema Peripheral |
0.7% |
| Prostatomegaly |
0.7% |
| Fluid Retention |
0.7% |
| Hair Transplant |
0.7% |
| Hypercholesterolaemia |
0.7% |
|
| Dizziness |
19.7% |
| Loss Of Consciousness |
10.4% |
| Haematuria |
9.8% |
| Ventricular Extrasystoles |
9.8% |
| Hyperthyroidism |
6.6% |
| Electrocardiogram Pr Prolongation |
4.9% |
| Sexual Dysfunction |
4.9% |
| Tremor |
4.9% |
| Intentional Drug Misuse |
3.8% |
| Drug Interaction |
2.7% |
| Erectile Dysfunction |
2.7% |
| Metabolic Alkalosis |
2.7% |
| Oedema Peripheral |
2.7% |
| Urine Flow Decreased |
2.7% |
| Prostatic Specific Antigen Increased |
2.2% |
| Respiratory Failure |
2.2% |
| Wrong Technique In Drug Usage Process |
2.2% |
| Arthralgia |
1.6% |
| Depression |
1.6% |
| Drug Ineffective |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.6% |
| Drug Use For Unknown Indication |
10.5% |
| Hypertension |
8.8% |
| Benign Prostatic Hyperplasia |
4.8% |
| Atrial Fibrillation |
3.5% |
| Prostatic Disorder |
3.1% |
| Diabetes Mellitus |
2.8% |
| Blood Cholesterol Increased |
2.7% |
| Pain |
2.7% |
| Prostatomegaly |
2.1% |
| Prophylaxis |
2.0% |
| Multiple Myeloma |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Depression |
1.8% |
| Rheumatoid Arthritis |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Cardiac Disorder |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Anxiety |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Weight Decreased |
9.3% |
| Drug Ineffective |
8.2% |
| Death |
7.8% |
| Vomiting |
7.5% |
| Pneumonia |
6.1% |
| Renal Failure Acute |
5.0% |
| Syncope |
5.0% |
| Thrombocytopenia |
4.5% |
| Dyspnoea |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Dizziness |
4.2% |
| Tremor |
4.0% |
| Vision Blurred |
4.0% |
| Myelodysplastic Syndrome |
3.9% |
| Urinary Tract Infection |
3.9% |
| Weight Increased |
3.9% |
| Urinary Retention |
3.8% |
| Pruritus |
3.5% |
| Myocardial Infarction |
3.3% |
| Diarrhoea |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
66.7% |
| Constipation |
8.3% |
| Prostatic Disorder |
8.3% |
| Macular Degeneration |
4.2% |
| Pollakiuria |
4.2% |
| Prostatomegaly |
4.2% |
| Wheezing |
4.2% |
|
| Abdominal Pain |
25.0% |
| Drug Ineffective |
25.0% |
| Nocturia |
25.0% |
| Renal Failure Chronic |
25.0% |
|
